This article highlights the fundamentals of EU medical device regulation, highlight the top priorities for 2023, and explore how individuals and organizations can become more involved in the changing landscape.
Table of Contents
The European Union (EU) has implemented new regulations that significantly impact the medical device industry. These regulations, known as the EU Medical Device Regulation (MDR), have been enforced since May 2021.
As we move further into 2023, it is essential to understand the key aspects of the MDR and the priorities it sets for the medical device industry.
EU Medical Device Regulation
The EU MDR represents a significant shift in how medical devices are regulated within the EU. It replaces the previous Medical Device Directive (MDD) and introduces more stringent requirements for manufacturers, importers, and distributors.
Key elements of the MDR include:
- Expanded scope: The MDR covers a broader range of medical devices, including software.
- Stricter classification system: The rules have been updated, and some devices previously considered low risk are now subject to more rigorous scrutiny.
- Enhanced post-market surveillance: Manufacturers are required to establish systems for post-market surveillance, including monitoring device performance, conducting periodic safety reports, and managing field safety corrective actions.
- Unique Device Identification (UDI): All medical devices must carry a UDI code, allowing for better traceability and improved post-market surveillance.
- Clinical evidence requirements: Manufacturers must provide robust clinical evidence to demonstrate the safety and performance of their devices.
- Strengthened oversight of Notified Bodies: Notified Bodies, have been subjected to stricter requirements and increased surveillance by regulatory authorities.
Top EU Medical Device Regulation Priorities for 2023
In 2023, certain priorities emerged within the EU medical device regulatory landscape. These include:
- Implementation OF EU MDR extension: The MDR, which came into effect in 2017, has a transition period ending on 31 December 2027 or 31 December 2028, as applicable, Manufacturers must ensure compliance with the new requirements, including stricter classification rules, enhanced post-market surveillance, and increased transparency.
- Commission Guidance on the content and structure of the summary of the clinical investigation report (Text with EEA relevance) 2023/C 163/06
- Transitioning Legacy Devices: Companies will continue efforts to transition their legacy devices from MDD to MDR compliance, ensuring a smooth process to meet the required timelines.
- Post-Market Surveillance and Vigilance: The emphasis on post-market surveillance will remain crucial, with manufacturers enhancing their systems for monitoring device safety and effectiveness throughout their lifecycle.
- Collaboration and Information Exchange: MDCG 2020-3 Rev.1 – Guidance on significant changes regarding the transitional provision under Article 120 of the MDR May 2023
How to get more Involved?
As the EU medical device industry adapts to the MDR, it is essential for stakeholders to become more involved and stay updated. Here are some steps to consider:
- Stay Informed: Keep up with the latest developments and guidance on the MDR from authoritative sources like the European Commission, national competent authorities, and industry associations.
- Engage with Industry Associations: Join relevant industry associations or trade groups that provide valuable resources, webinars, and networking opportunities.
- Collaborate with Regulatory Bodies: Participate in workshops, conferences, and consultations organized by regulatory bodies to gain insights, ask questions, and contribute to the regulatory decision-making process.
- Evaluate and Enhance Compliance Processes: Review the compliance processes and identify areas that need improvement to align with the new MDR requirements.
- Train and educate your personnel: Provide training sessions and workshops for EU MDR to enhance personnel’s understanding.
- Establish Strong Quality Management Systems: This includes effective document control, risk management, and post-market surveillance processes.
- Consider Third-Party Expertise: If needed, seek assistance from regulatory consultants or experts who specialize in EU medical device regulations.
- Engage in Notified Body Selection: As the MDR strengthens oversight of Notified Bodies, carefully evaluate and select a reliable and accredited Notified Body for conformity assessment. This choice can greatly impact the efficiency of compliance process.
- Monitor Regulatory Updates: Monitor any updates or amendments to the MDR.Manage the device lifecycle accordingly.
The EU Medical Device Regulation in 2023 introduces significant changes to the medical device industry within the European Union.
Manufacturers, importers, and distributors must understand the new requirements and priorities to ensure compliance and maintain market access.
By staying informed, engaging with industry associations, collaborating with regulatory bodies, enhancing compliance processes, and seeking expert guidance, when necessary, stakeholders can navigate the evolving landscape effectively.
How Can RegDesk Help?
RegDesk is a holistic Regulatory Information Management System that provides medical device and pharma companies with regulatory intelligence for over 120 markets worldwide. It can help you prepare and publish global applications, manage standards, run change assessments, and obtain real-time alerts on regulatory changes through a centralized platform. Our clients also have access to our network of over 4000 compliance experts worldwide to obtain verification on critical questions. Global expansion has never been this simple.